Caffeine and Cerebrovascular Reactivity

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

August 1, 2022

Conditions
Caffeine
Interventions
DRUG

Caffeine

Caffeine, also known as Trimethylxanthine, will be purchased through the University of Oklahoma Health Sciences Pharmacy and formulated into capsule pills containing 100mg of active ingredient

DRUG

Placebo

Placebo pill will be formulated with a non active ingredient such as rice flour powder

Trial Locations (1)

73117

Translational GeroScience Laboratory, Oklahoma City

All Listed Sponsors
lead

University of Oklahoma

OTHER

NCT04730193 - Caffeine and Cerebrovascular Reactivity | Biotech Hunter | Biotech Hunter